Breakout Sessions : Update on the Evolving Global Gene Therapy Regulatory Policy Landscape

jun 3, 2019: 2:30 p.m. - 3:45 p.m.
118A, Level 100

Scientific technology for gene therapy has made tremendous progress and the regulatory landscape is still developing. Both the FDA and EMA have issued recommendations for gene therapies. Panelists will discuss recent updates to the policy landscape for in vivo and ex vivo gene therapy as well as opportunities for harmonization.

Speakers

Snehal Naik
Associate Director, Gl...

Rune Kjeken
Scientific Director, A...

Wilson Bryan
Director, Office of Ti...

Mo Heidaran
Vice President Technic...

Mantej (Nimi) Chhina
Director, Regulatory P...

Tania Teixeira
EMA Liaison Official a...